Carroll Financial Associates’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$23K Sell
360
-1,001
-74% -$64.1K ﹤0.01% 931
2021
Q3
$85K Sell
1,361
-121
-8% -$7.72K ﹤0.01% 582
2021
Q2
$89K Buy
1,482
+216
+17% +$12.5K 0.01% 616
2021
Q1
$69K Sell
1,266
-10,812
-90% -$600K ﹤0.01% 680
2020
Q4
$658K Buy
12,078
+1,152
+11% +$60.2K 0.04% 205
2020
Q3
$545K Buy
10,926
+480
+5% +$23.2K 0.04% 209
2020
Q2
$461K Buy
10,446
+1,518
+17% +$64.9K 0.04% 230
2020
Q1
$335K Sell
8,928
-4,026
-31% -$170K 0.03% 242
2019
Q4
$570K Sell
12,954
-594
-4% -$25K 0.05% 202
2019
Q3
$558K Sell
13,548
-60
-0.4% -$2.46K 0.05% 199
2019
Q2
$546K Buy
13,608
+8,622
+173% +$326K 0.05% 200
2019
Q1
$192K Buy
+4,986
New +$181K 0.02% 330

Other funds holding IHI

Carroll Financial Associates's IHI Position: Q4 2021 in Review

Carroll Financial Associates reduced its iShares US Medical Devices ETF (IHI) stake by 74% in Q4 2021, selling an estimated $64.1K and leaving 360 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Carroll Financial Associates first reported a position in IHI in Q1 2019 and has held it in 12 quarters since. The position peaked at $658K in Q4 2020. 662 funds tracked by Wall St. Rank hold IHI as of Q4 2021.

  • Carroll Financial Associates held 360 shares of iShares US Medical Devices ETF worth $23K as of Q4 2021.
  • Carroll Financial Associates sold 1,001 iShares US Medical Devices ETF shares in Q4 2021, an estimated $64.1K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #931 holding.
  • Carroll Financial Associates first reported a position in iShares US Medical Devices ETF in Q1 2019 and has held it in 12 quarters since.
  • Carroll Financial Associates's iShares US Medical Devices ETF position peaked at $658K in Q4 2020.
  • 662 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.